EcoDrugPlus

Ensembl ID : ML154151a
Gene Symbol: -
External references: -
219 Possible Orthologues:

Ensembl ID : ML154157a
Gene Symbol: -
External references: -
102 Possible Orthologues:

Ensembl ID : ML154192a
Gene Symbol: -
External references: -
108 Possible Orthologues:

Ensembl ID : ML154196a
Gene Symbol: -
External references: -
111 Possible Orthologues:

Ensembl ID : ML154513a
Gene Symbol: -
External references: -
143 Possible Orthologues:

Ensembl ID : ML154514a
Gene Symbol: -
External references: -
137 Possible Orthologues:

Ensembl ID : ML15633a
Gene Symbol: -
External references: -
261 Possible Orthologues:

Ensembl ID : ML15636a
Gene Symbol: -
External references: -
462 Possible Orthologues:

Ensembl ID : ML15994a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML16126a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML16211a
Gene Symbol: -
External references: -
260 Possible Orthologues:

Ensembl ID : ML165814a
Gene Symbol: -
External references: -
111 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).